Protein Therapeutics Market 2017 Trends, Growth and Forecast to 2021
ReportsWeb.com published “Protein Therapeutics Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, January 16, 2017 ) Therapeutic proteins are used to effectively treat a wide array of diseases such as protein deficiency diseases; chronic diseases such as cancer, rheumatoid arthritis (RA) , ankylosing spondylitis, diabetes; infections such as human immunodeficiency virus (HIV) , hepatitis A, hepatitis B, and hepatitis C; and other medical conditions such as genetic disorders, anemia cases related to kidney dialysis, and cancer-related anemia. Therapeutic proteins mostly consist of recombinant forms of naturally occurring proteins.
Publisher's analysts forecast the global protein therapeutics market to grow at a CAGR of 7.86% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-protein-therapeutics-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global protein therapeutics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded and biosimilar drugs used for the treatment of various diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Publisher's report, Global Protein Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-AbbVie
-Amgen
-F. Hoffmann-La Roche
-Johnson & Johnson
-Merck
-Novo Nordisk
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001539534/sample .
Other prominent vendors
-Anhui Anke Biotechnology (Group)
-AstraZeneca
-Baxter International
-Biocon
-Biodel
-BioGenomics
-Biopartners
-Boehringer Ingelheim
-Bristol-Myers Squibb
-Celltrion
-Chugai Pharmaceutical
-Diamyd Medical
-Diasome Pharmaceuticals
-DiaVacs
-Dynavax Technologies
-Eli Lilly
-Ferring Pharmaceuticals
-Generex Biotechnology
-GeneScience Pharmaceuticals
-Hualan Biological Engineering
-Intas Pharmaceuticals
-Ipsen
-JCR Pharmaceuticals
-Kyowa Hakko Kirin
-Lexicon Pharmaceuticals
-LG Life Sciences
-MacroGenics
-MannKind
-Oramed Pharmaceuticals
-Osiris Therapeutics
-Pfizer
-Sandoz International
-Sanofi
-Teva Pharmaceutical Industries
-Thermalin Diabetes
-Tolerion
-Wockhardt
-XOMA
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001539534/buying .
Publisher's analysts forecast the global protein therapeutics market to grow at a CAGR of 7.86% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-protein-therapeutics-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global protein therapeutics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded and biosimilar drugs used for the treatment of various diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Publisher's report, Global Protein Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-AbbVie
-Amgen
-F. Hoffmann-La Roche
-Johnson & Johnson
-Merck
-Novo Nordisk
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001539534/sample .
Other prominent vendors
-Anhui Anke Biotechnology (Group)
-AstraZeneca
-Baxter International
-Biocon
-Biodel
-BioGenomics
-Biopartners
-Boehringer Ingelheim
-Bristol-Myers Squibb
-Celltrion
-Chugai Pharmaceutical
-Diamyd Medical
-Diasome Pharmaceuticals
-DiaVacs
-Dynavax Technologies
-Eli Lilly
-Ferring Pharmaceuticals
-Generex Biotechnology
-GeneScience Pharmaceuticals
-Hualan Biological Engineering
-Intas Pharmaceuticals
-Ipsen
-JCR Pharmaceuticals
-Kyowa Hakko Kirin
-Lexicon Pharmaceuticals
-LG Life Sciences
-MacroGenics
-MannKind
-Oramed Pharmaceuticals
-Osiris Therapeutics
-Pfizer
-Sandoz International
-Sanofi
-Teva Pharmaceutical Industries
-Thermalin Diabetes
-Tolerion
-Wockhardt
-XOMA
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001539534/buying .
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results